PRTC Valuation

PureTech Health PLC

Add to Watchlist

Advanced Chart

19.069

+0.069(0.363%)1D

Overview
Forecast
Valuation
Earnings

PRTC Relative Valuation

PRTC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PRTC is overvalued; if below, it's undervalued.

Historical Valuation

PureTech Health PLC (PRTC) is now in the Undervalued zone, suggesting that its current forward PS ratio of 17.24 is considered Undervalued compared with the five-year average of -5.48. The fair price of PureTech Health PLC (PRTC) is between 4366.33 to 4452.25 according to relative valuation methord. Compared to the current price of 19.07 USD , PureTech Health PLC is Undervalued By 99.56%.

Relative Value

Fair Zone

4366.33-4452.25

Current Price：19.07

99.56%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

10.97

P/B

Median3y

4.11

Median5y

3.20

-28.71

FCF Yield

Median3y

-23.07

Median5y

-19.44

Competitors Valuation Multiple

The average P/S ratio for PRTC's competitors is 17074.94, providing a benchmark for relative valuation. PureTech Health PLC Corp (PRTC) exhibits a P/S ratio of 17.24, which is -99.90% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PRTC.O

PureTech Health PLC

17.24

Average P/S: 17074.94

4.59B